Profound difference in pharmacokinetics between morin and its isomer quercetin in rats

J Pharm Pharmacol. 2003 Feb;55(2):199-203. doi: 10.1211/002235702487.

Abstract

Morin and quercetin are isomeric antioxidant flavonols widely distributed in plant foods and herbs. The pharmacokinetics of both flavonols at two doses were investigated and compared in rats. Parent forms and their glucuronides and sulfates in serum were determined by HPLC before and after enzymatic hydrolysis, respectively. After oral dosing of morin, both the parent form, morin, and its glucuronides and sulfates were present in the bloodstream. The conjugated metabolites predominated at the dose of 25 mg kg(-1), whereas the parent form was predominant at the dose of 50 mg kg(-1). Moreover, the AUC of morin parent form increased by a factor of 37 when the dose doubled, indicating that morin showed nonlinear pharmacokinetics. On the other hand, quercetin presented only as glucuronides and sulfates in the blood, indicating negligible bioavailability of quercetin, and the metabolites showed linear pharmacokinetics at the two doses studied. When considering the total AUC of parent form with conjugated metabolites, the extent of absorption of morin was 3 fold that of quercetin at the dose of 50 mg kg(-1). The results indicated that the difference in hydroxylation pattern on B-ring of flavonol markedly affected their fates in rats.

MeSH terms

  • Administration, Oral
  • Animals
  • Area Under Curve
  • Flavonoids / blood
  • Flavonoids / metabolism
  • Flavonoids / pharmacokinetics*
  • Half-Life
  • Intestinal Absorption
  • Isomerism
  • Male
  • Quercetin / blood
  • Quercetin / metabolism
  • Quercetin / pharmacokinetics*
  • Rats
  • Rats, Sprague-Dawley
  • Structure-Activity Relationship

Substances

  • Flavonoids
  • morin
  • Quercetin